[fcb5af]: / literature / by_gene / POU2F2.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 33512466 10.1182/blood.2020010175 2021 OBF1 and Oct factors control the germinal center transcriptional program. POU2F2
2 34461601 10.1016/j.ebiom.2021.103559 2021 Loss of synergistic transcriptional feedback loops drives diverse B-cell cancers. POU2F2
3 26993806 10.1073/pnas.1600557113 2016 Regulation of normal B-cell differentiation and malignant B-cell survival by OCT2. POU2F2
4 27009953 10.1128/JVI.00239-16 2016 HCF1 and OCT2 Cooperate with EBNA1 To Enhance OriP-Dependent Transcription and Episome Maintenance of Latent Epstein-Barr Virus. POU2F2
5 25765478 10.1186/s12864-015-1303-0 2015 Genome-wide comparison of PU.1 and Spi-B binding sites in a mouse B lymphoma cell line. POU2F2
6 24344258 10.1073/pnas.1321704111 2014 Epstein-Barr virus nuclear antigen 3C binds to BATF/IRF4 or SPI1/IRF4 composite sites and recruits Sin3A to repress CDKN2A. POU2F2
7 24435047 10.1182/blood-2013-05-500264 2014 Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma. POU2F2
8 23292937 10.1073/pnas.1205299110 2013 Genetic heterogeneity of diffuse large B-cell lymphoma. POU2F2
9 22346751 10.1371/journal.ppat.1002516 2012 The B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1. POU2F2
10 21424034 2011 B-cell transcription factors Pax-5, Oct-2, BOB.1, Bcl-6, and MUM1 are useful markers for the diagnosis of nodular lymphocyte predominant Hodgkin lymphoma. POU2F2
11 22158496 10.1700/989.10724 2011 Immunohistochemical expression of Mum-1, Oct-2 and Bcl-6 in systemic anaplastic large cell lymphomas. POU2F2
12 20141429 10.3109/10428191003592735 2010 OCT-2 expression and OCT-2/BOB.1 co-expression predict prognosis in patients with newly diagnosed acute myeloid leukemia. POU2F2
13 18695675 10.1038/onc.2008.286 2008 Functional long-range interactions of the IgH 3' enhancers with the bcl-2 promoter region in t(14;18) lymphoma cells. POU2F2
14 16186795 10.1038/sj.onc.1209127 2006 Oct transcription factors mediate t(14;18) lymphoma cell survival by directly regulating bcl-2 expression. POU2F2
15 15796964 10.1016/j.cancergencyto.2004.09.005 2005 Alterations of loci encoding PU.1, BOB1, and OCT2 transcription regulators do not correlate with their suppressed expression in Hodgkin lymphoma. POU2F2
16 14707079 10.4049/jimmunol.172.2.1054 2004 NF-kappa B and Oct-2 synergize to activate the human 3' Igh hs4 enhancer in B cells. POU2F2
17 15257313 10.1038/modpathol.3800227 2004 Analysis of transcription factor OCT.1, OCT.2 and BOB.1 expression using tissue arrays in classical Hodgkin's lymphoma. POU2F2
18 12507907 10.1016/s0002-9440(10)63815-1 2003 Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins. POU2F2
19 12592383 10.1038/sj.onc.1206270 2003 Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines. POU2F2
20 12598320 10.1016/S0002-9440(10)63882-5 2003 Expression of B-lymphocyte-associated transcription factors in human T-cell neoplasms. POU2F2
21 12647220 10.1007/s00428-002-0735-5 2003 Expression patterns of transcription factors in progressively transformed germinal centers and Hodgkin lymphoma. POU2F2
22 12848851 10.1046/j.0818-9641.2003.01172.x 2003 Knockout B lymphoma cell lines as biochemical tools to explore multiple signalling pathways. POU2F2
23 14608905 10.1309/YCH8-DWUF-FQBK-GPVB 2003 The B-cell transcription factors BSAP, Oct-2, and BOB.1 and the pan-B-cell markers CD20, CD22, and CD79a are useful in the differential diagnosis of classic Hodgkin lymphoma. POU2F2
24 14662861 10.4049/jimmunol.171.12.6589 2003 Critical role for the Oct-2/OCA-B partnership in Ig-secreting cells. POU2F2
25 11929801 10.1182/blood.v99.8.3060 2002 Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease. POU2F2
26 11154228 10.1182/blood.v97.2.496 2001 Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. POU2F2
27 11280769 2001 Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cells. POU2F2
28 11696441 10.1016/S0002-9440(10)63027-1 2001 The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease. POU2F2
29 10727398 2000 Phosphorylation of Oct-2 at sites located in the POU domain induces differential down-regulation of Oct-2 DNA-binding ability. POU2F2
30 9925930 10.1159/000015128 1998 Transcription factor effects on chromosome constitution of cell hybrids. POU2F2
31 8537118 10.1007/BF00186600 1996 The function of the octamer-binding site in the DRA promoter. POU2F2
32 8639794 1996 High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells. POU2F2
33 7486513 10.1111/j.1749-6632.1995.tb55817.x 1995 Role of Oct-2 in immunoglobulin gene silencing. POU2F2
34 7868225 10.1128/iai.63.3.1040-1046.1995 1995 Diphosphoryl lipid A from Rhodobacter sphaeroides transiently activates NF-kappa B but inhibits lipopolysaccharide induction of kappa light chain and Oct-2 in the B-cell lymphoma line 70Z/3. POU2F2
35 7600290 10.1016/1074-7613(94)90034-5 1994 Constitutively expressed Oct-2 prevents immunoglobulin gene silencing in myeloma x T cell hybrids. POU2F2
36 7813434 10.1002/j.1460-2075.1994.tb06942.x 1994 Transformation by homeobox genes can be mediated by selective transcriptional repression. POU2F2
37 8039828 10.1007/BF00167080 1994 Two different IFN-gamma nonresponsive variants derived from the B-cell lymphoma 70Z/3. POU2F2
38 8121549 1994 Primary brain tumors differ in their expression of octamer deoxyribonucleic acid-binding transcription factors from long-term cultured glioma cell lines. POU2F2
39 1937571 1991 Differentiation of human B-cell malignant lymphomas is independent of the octamer lymphoid specific binding factor (Oct-2). POU2F2
40 1689272 10.1007/BF00661216 1990 1.3E2, a variant of the B lymphoma 70Z/3, defective in activation of NF-kappa B and OTF-2. POU2F2